VEGF beta is a candidate biomarker for cardiovascular risk stratification

Back

ESC Professional Premium Access

VEGF beta is a candidate biomarker for cardiovascular risk stratification

Session: Biomarkers and more

Topic: Biomarkers

Speaker: Doctor C. Schulte (Hamburg, DE)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Christian Schulte

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

1 presentation

0 follower

8 more presentations in this session

Patients with known coronary artery disease who are ruled out for acute myocardial infarction using a high sensitivity troponin T 0/1-hour algorithm have increased 30-day major adverse cardiac events

Speaker: Professor R. Nowak (Detroit, US)

Access

Abstract

Slides

Differences in circulating cardiac troponin I and T in acute and chronic cardiac disease

Speaker: Doctor T. Zimmermann (Basel, CH)

Access

Abstract

Slides

Growth differentiation factor 15 at 3 months after an acute chest pain admission is associated with increased risk of death and cardiovascular events

Speaker: Doctor G. Myrmel (Bergen, NO)

Access

Abstract

Slides

Direct comparison of very early AMI rule-out algorithms

Speaker: Doctor C. Pedersen (Aarhus, DK)

Access

Abstract

Slides

Serial high-sensitivity troponin T concentrations and long-term outcomes in patients with suspected acute coronary syndrome

Speaker: Doctor M. Pareek (Copenhagen, DK) Doctor A. Kristensen (Frederiksberg, DK)

Access

Abstract

Slides

Access the full session

Biomarkers and more

Speakers: Doctor C. Schulte, Professor R. Nowak, Doctor T. Zimmermann, Doctor G. Myrmel, Doctor C. Pedersen...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources